First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies

H. Namkoong, T. Asakura, M. Ishii, S. Yoda, K. Masaki, T. Sakagami, E. Iwasaki, Y. Yamagishi, T. Kanai, T. Betsuyaku, N. Hasegawa

Research output: Contribution to journalArticlepeer-review

Abstract

This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.

Original languageEnglish
Pages (from-to)4-6
Number of pages3
JournalNew Microbes and New Infections
Volume27
DOIs
Publication statusPublished - 2019 Jan

Keywords

  • Anti–interferon gamma (IFN-γ) autoantibody
  • Mycobacterium aviumcomplex (MAC)
  • disseminated Mycobacterium aviumcomplex infection
  • hepatobiliary infection
  • jaundice

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies'. Together they form a unique fingerprint.

Cite this